Nuformix (LON:NFX) Trading Down 32.4% – Here’s What Happened

Nuformix plc (LON:NFX) shares were down 32.4% on Wednesday . The stock traded as low as GBX 0.10 ($0.00) and last traded at GBX 0.10 ($0.00). Approximately 343,525,563 shares changed hands during trading, an increase of 375% from the average daily volume of 72,272,914 shares. The stock had previously closed at GBX 0.15 ($0.00).

Nuformix Price Performance

The company has a quick ratio of 3.35, a current ratio of 1.12 and a debt-to-equity ratio of 1.17. The stock has a market capitalization of £622,675.60, a price-to-earnings ratio of -1.63 and a beta of 1.22. The business’s 50 day simple moving average is GBX 0.06 and its 200-day simple moving average is GBX 0.10.

Nuformix (LON:NFX) last announced its quarterly earnings data on Wednesday, January 29th. The company reported GBX (0.46) (($0.01)) earnings per share (EPS) for the quarter.

Nuformix Company Profile

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.